Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. The most common cause of mortality in NAFLD is cardiovascular disease (CVD), and a key of focus in drug development is to discover therapies that target both liver injury and CVD risk. NAFLD and CV...
Saved in:
Main Authors: | Karthik Chandrasekharan (Author), William Alazawi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic Aspects of Non-Alcoholic Fatty Liver Disease
by: Pavel O. Bogomolov, et al.
Published: (2019) -
Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
by: Rosa Lombardi, et al.
Published: (2021) -
Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
by: Johanna C. Arroyave-Ospina, et al.
Published: (2021) -
Non-alcoholic fatty liver disease and cardiovascular risks: A review
by: Yulia V. Kotovskaya
Published: (2023) -
BIOCHEMICAL AND CLINICAL PERIODONTAL IMPLICATIONS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: Petra Șurlin, et al.
Published: (2020)